Nxera Team


Our management team, board and scientific advisory board have vast experience in the global pharma industry and provide a wealth of expertise.

A portrait of Mr. Toshi Maeda

Mr. Toshi Maeda

Executive Vice President, Chief Operating Officer

Toshihiro Maeda joins from Bristol Myers Squibb (“BMS”), where he led a Business Unit and was instrumental in the post-merger integration of Celgene’s businesses and commercial strategies for the combined group in Japan. He brings with him a breadth of global management and commercialization experience and a strong background rooted in the pharmaceutical industry. Prior to BMS, he worked at Merck & Co in both Japan and the US where he held senior partnering and commercialization roles in its oncology and diabetes business units. He also worked at McKinsey and Company in Japan and the UK where he gained global business experience in healthcare industry. Mr. Maeda holds an MBA from The University of Chicago Booth School of Business in the US.

Toshihiro was appointed as Chief Operating Officer of Nxera Pharma in December 2023.